Article Text

Download PDFPDF
Smoking, use of oral contraceptives, and medical induction of remission were risk factors for relapse in Crohn’s disease
  1. R F A LOGAN
  1. Dept of Public Health and Epidemiology,
  2. University of Nottingham Medical School,
  3. Queen’s Medical Centre,
  4. Clifton Boulevard,
  5. Nottingham NG7 2UH, UK

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Epidemiological studies reporting positive associations between smoking and oral contraceptives (OC) and Crohn’s disease first appeared in the mid-1980s. Subsequently neither association has been found to be especially strong (relative risks around 3 for smoking and 2 for OC) and there continues to be uncertainty as to whether or not these are causal associations.1 Smoking and OC use also confound one another, with OC use being more common in smokers.

In contrast to the association between Helicobacter pylori and duodenal ulcer, it is not possible to test the reversibility of the associations by randomised trials. A less rigorous test of causation is to observe the relations between these factors and prognosis of Crohn’s disease as Timmer et al have done. Examining prognosis in the context of a controlled trial has several attractions—prospective data recording, minimal problems of misclassification and unbiased assessment of outcome.

Their twofold increase in relapse rate for current smokers is consistent with earlier retrospective studies. The relapse rate is less well-established in ex-smokers. Retrospective assessment of ex-smoking presents …

View Full Text

Footnotes

  • Source of funding: German Academic Exchange Service.

  • For correspondence: Dr L R Sutherland, Department of Community Health Sciences, University of Calgary, 3300 Hospital Drive Northwest, Calgary, AB T2N 4N1, Canada. FAX +1 403 270 7307.